Stem Cell
In ESC, BMP/TGF-β signaling pathway plays a key role in maintaining pluripotency and self-renewal. It signals through Smad proteins, and the FGF signaling pathway, which activates the MAPK and Akt pathways. The Wnt signaling pathway also promotes pluripotency. OCT-4, SOX2, and NANOG are three main transcription factors that are expressed and activated by these pathways. Induced pluripotent stem cells (iPSC) are pluripotent cells that can be generated from differentiated cells with forced expression of specific reprogramming factors. Both ESC and iPSC can be induced to develop into distinct cell types that associated with three primary germ layers: ectoderm, mesoderm and endoderm. Signaling pathways that control the development of these cell lineages, including BMP/TGF-β, Notch, Wnt/β-catenin, Hedgehog and Hippo pathways, which regulate cell division, growth and differentiation. Defects in stem cell signaling are related to developmental disorders and cancer.
-
B1539 Tideglusib1 CitationSummary: non-ATP-competitive GSK-3β inhibitor
-
B1021 EI1Summary: EZH2 inhibitor
-
B1237 LH846Summary: Casein kinases inhibitor
-
B2266 LDE225 (NVP-LDE225,Erismodegib)1 CitationTarget: SmoothenedSummary: Smoothened inhibitor,potent and selective
-
B1538 GSK-3 Inhibitor IX (BIO)Summary: GSK-3α/GSK-3β inhibitor, cell-permeable, ATP-competitive and reversible
-
B2306 IWR-1-endo1 CitationSummary: Potent Wnt signaling inhibitor
-
A8500 PF-5274857Summary: Smo antagonist,potent and selective
-
A8395 CHIR-98014Target: GSK-3Summary: GSK-3β inhibitor,selective and ATP-competitive
-
A8396 CHIR-99021 (CT99021) HClTarget: GSK-3Summary: GSK-3α/β inhibitor
-
A8600 Tankyrase Inhibitors (TNKS) 22Summary: Tankyrase inhibitor